Sort
261,768 grants matching “gene therapy”
Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section
$1,053,823Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Center for Fetal Gene Transfer for Heart, Lung, and Blood Diseases
$1,053,634Alice F Tarantal · University Of California At Davis · R24 · FY2016 · HL
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
$1,053,550David A Stoltz · University Of Iowa · R01 · FY2021 · HL
Targeting eIF4A1 in drug-resistant breast cancer stem-like cells
$1,053,488Dayanidhi Raman · University Of Toledo Health Sci Campus · R01 · FY2025 · CA
Vermont Breast Cancer Molecular Characterization Laboratory
$1,053,429Janet L Stein · University Of Vermont & St Agric College · U01 · FY2018 · CA
Molecular Dynamics Simulations Of Biological Macromolecules
$1,052,650Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Transcriptional regulation of inflammatory and autoimmune responses
$1,052,527Vanja Lazarevic · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
$1,052,527Vanja Lazarevic · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Oncogenic Kinase complexes
$1,052,452Ping Zhang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer
$1,052,251Loren D Walensky · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Biology of the Lung: A Multidisciplinary Program
$1,052,020David M Center · Boston University Medical Campus · T32 · FY2012 · HL
Biology of the Lung: A Multidisciplinary Program
$1,052,020David M Center · Boston University Medical Campus · T32 · FY2013 · HL
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,051,939Nora M Navone · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA
iPS-technology and patient specific disease models
$1,051,897Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
New Strategies for Cancer Drug Discovery: Integrative Pharmacogenomics and Pharm
$1,051,653John N Weinstein · Basic Sciences · Z01 · FY2007 · CA
PreCharge: An Innovative Digital Program to Increase Coping, Resilience, and Health Care Engagement Among Cancer Previvors
$1,051,590Kerry Evers · Pro-Change Behavior Systems, Inc. · R44 · FY2025 · CA
Genetic Determinants of Antidepressant Response in the STAR*D Cohort
$1,051,501Francis J McMahon · National Institute Of Mental Health · ZIA · FY2010 · MH
A STINGing vaccine for TB
$1,051,436William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI
Integrated Systems Biology Approach to Diabetic Microvascular Complications
$1,051,333Frank C Brosius · University Of Michigan At Ann Arbor · R24 · FY2012 · DK
Molecular Imaging & Targeted Therapeutics of Stem Cell-Derived Colon Cancer
$1,051,262Robert J Coffey · Vanderbilt University · P50 · FY2012 · CA
Development of a novel SP-B peptide lung surfactant
$1,051,147Gary Fujii · Molecular Express, Inc. · R44 · FY2014 · HL
RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES
$1,051,117University Of Florida · P01 · FY2004 · DK
Nanotechnology Targeting Novel CD154:CD11b Interactions for Transplant Tolerance
$1,051,096Mandy L. Ford · University Of Minnesota · U19 · FY2024 · AI
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
$1,050,989Debra L Friedman · Vanderbilt University Medical Center · UG3 · FY2022 · CA
Identification and use of T-cell receptors recognizing common tumor mutations
$1,050,974James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA